Clinical trials

Condition   Drug Name  
Study IGIV in atopic dermatitis
Patients 2
Treatment Regimen IGIV, 0.5 mg/kg/d i.v. x 4 d (n=1); IGIV, 0.4 mg/kg/d i.v. x 5 d + Steroids top. (n=1)
Conclusions IGIV was well tolerated and reduced atopic eczema symptoms in two women
Reference(s) Intravenous immunoglobulin for the treatment of severe, recalcitrant atopic eczema in the elderly
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-110.
Author and Affiliation Fallon, J., Murphy, G.M.